D. E. Shaw & Co., Inc. Xoma Corp Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$33.21 - $43.99 $159,939 - $211,855	-4,816 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.26 - $45.61 $92,756 - $219,657	4,816 New	4,816 $213,000
Q1 2020 May 15, 2020	SELL	$15.11 - $28.71 $144,421 - $274,410	-9,558 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.5 - $28.66 $167,265 - $273,932	9,558 New	9,558 $261,000
Q1 2018 May 15, 2018	SELL	$19.86 - $35.92 $310,749 - $562,040	-15,647 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$19.71 - $36.79 $1.17 Million - $2.18 Million	-59,281 Reduced 79.12%	15,647 $557,000
Q3 2017 Nov 14, 2017	BUY	$7.31 - $20.8 $547,723 - $1.56 Million	74,928	74,928 $1.47 Million

6.5M

100

1.6K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $344M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.